New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

AIDP granted U.S. patent for Magtein

AIDP granted U.S. patent for Magtein
Patent covers magnesium compositions and uses for metabolic disorders.

AIDP Inc., the distributor of Magtein™ magnesium L-threonate, expected to be the next breakthrough ingredient for cognitive health, has been awarded a patent for Magtein’s unique magnesium compositions and its uses for metabolic disorders (Patent 8,163,301).

The patent, titled “Magnesium compositions and uses thereof for metabolic disorders,” is the one of seven ongoing patent applications including international rights awarded. This patent protects Magtein’s unique magnesium compositions and the use of magnesium-containing food, nutritional supplements and drugs to consumers in need for supplementing a magnesium-containing compound in an amount that is effective to ameliorate said effect of the metabolic disorder, wherein the magnesium-containing compound comprises magnesium L-threonate. Metabolism is the process your body uses to make energy from food. When this process is disrupted, it is called metabolic disorder. Typical metabolic disorders include, but are not limited to, obesity and diabetes. Other patents include magnesium compositions and uses thereof for neurological disorders (Patent 8,142,803) and food compositions (Patent 8,178,132).

“We truly believe Magtein is a game changing ingredient that will benefit millions of busy and stressed consumers by helping to improve their quality of life,” says Edward Lee Ph.D., AIDP president.

“AIDP, as the exclusive supplier of Magtein magnesium L-threonate, is uniquely positioned to serve the functional food and beverage marketplaces to support the cognitive health category,” added Dr. Lee.

Discovered by Guosong Liu, M.D., Ph.D., and a distinguished group of scientists at Massachusetts Institute of Technology (MIT), and Tsinghua University in Beijing, China, studies on Magtein have been published in prestigious journals of neuroscience—Neuron (January 2010) and The Journal of Neuroscience (October 2011). With cognitive diseases the seventh leading cause of death in the U.S. and growing at an alarming rate, Magtein, which has self-affirmed GRAS status, is the only form of magnesium proven to significantly increase brain magnesium levels. Furthermore, animal research showed Magtein improved short-term and long-term memory as well as spatial recognition.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.